Reductionism and proxy failure: From neuroscience to target-based drug discovery

被引:0
|
作者
Sadri, Arash [1 ,2 ]
Paknezhad, Sepideh [3 ]
机构
[1] Lyceum Sci Char, Tehran, Iran
[2] Univ Tehran Med Sci, Students Sci Res Ctr, Interdisciplinary Neurosci Res Program INRP, Tehran, Iran
[3] Islamic Azad Univ, Dept Psychol, Sari Branch, Sari, Iran
关键词
D O I
10.1017/S0140525X23002893
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Reductionist methodologies reduce phenomena to some of their lower-level components. Researchers gradually shift their focus away from observing the actual object of study toward investigating and optimizing such lower-level proxies. Following reductionism, these proxies progressively diverge further from the original object of study. We vividly illustrate this in the evolution of target-based drug discovery from rational and phenotypic drug discovery.
引用
收藏
页数:56
相关论文
共 50 条
  • [21] Target-based discovery of therapeutic agents from food ingredients
    Shiuan, David
    Tai, Da-Fu
    Huang, Kao-Jean
    Yu, Zhipeng
    Ni, Feng
    Li, Jianrong
    TRENDS IN FOOD SCIENCE & TECHNOLOGY, 2020, 105 : 378 - 384
  • [22] Surface plasmon resonance as a fascinating approach in target-based drug discovery and development
    Das, Shibam
    Singh, Sukhwinder
    Chawla, Viney
    Chawla, Pooja A.
    Bhatia, Rohit
    TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2024, 171
  • [23] TARGET-BASED DRUG DISCOVERY IN MALARIA: A NEW WAY TO IMPLEMENT AN OLD STRATEGY
    Alvaro, Elena Fernandez
    Harupa, Anke
    Kaushansky, Alexis
    Penzo, Maria
    Penzo, Maria
    Baker, David
    Herreros, Esperanza
    Ballell-Pages, Lluis
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 90 - 90
  • [24] Target-based discovery of crop protection chemicals
    Eric Ward
    Paul Bernasconi
    Nature Biotechnology, 1999, 17 : 618 - 619
  • [25] Target-based discovery of crop protection chemicals
    Ward, E
    Bernasconi, P
    NATURE BIOTECHNOLOGY, 1999, 17 (07) : 618 - 619
  • [26] In silico tools used for compound selection during target-based drug discovery and development
    Caldwell, Gary W.
    EXPERT OPINION ON DRUG DISCOVERY, 2015, 10 (08) : 901 - 923
  • [27] Harnessing the Versatility of Optical Biosensors for Target-Based Small-Molecule Drug Discovery
    Kaminski, Tim
    Gunnarsson, Anders
    Geschwindner, Stefan
    ACS SENSORS, 2017, 2 (01): : 10 - 15
  • [28] Weak links: Advancing target-based drug discovery by identifying the most vulnerable targets
    Bosch, Barbara
    Dejesus, Michael A.
    Schnappinger, Dirk
    Rock, Jeremy M.
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2024, 1535 (01) : 10 - 19
  • [29] Phenotypic vs. Target-Based Drug Discovery for First-in-Class Medicines
    Swinney, D. C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (04) : 299 - 301
  • [30] Designing innovative therapies for neuropathic pain: pros and cons of target-based drug discovery
    Inglese, J.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2014, 19 : S6 - S9